General
Preferred name
CEFAMANDOLE
Synonyms
Cefamandole sodium salt ()
Cefamandole (sodium) ()
Cephamandole sodium ()
CEFAMANDOLE SODIUM ()
Cefamandole (sodium salt) ()
NSC-758169 ()
Cefamandol ()
Compound 83405 ()
COMPOUND-83405 ()
J01DC03 ()
Cephamandole ()
P&D ID
PD009562
CAS
30034-03-8
34444-01-4
Tags
available
covalent binder
drug
drug candidate
Drug indication
Microorganisms infection
osteomyelitis
Drug Status
approved
experimental
investigational
Max Phase
2.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Cefamandole Sodium Salt is a second-generation broad-spectrum cephalosporin antibiotic.
PHARMACODYNAMICS The parenteral prodrug formate ester cefamandole nafate is a broad-spectrum cephalosporin antibiotic. The bactericidal action of cefamandole results from inhibition of cell-wall synthesis. Cephalosporins have in vitro activity against a wide range of gram-positive and gram-negative organisms.
DESCRIPTION Cefamandole is a semisynthetic, second generation cephalosporin belonging to the β-lactam class of antibacterial compounds . It has broad-spectrum activity and is β-lactamase-resistant. It is administered parenterally as the prodrug cefamandole nafate.
Because of its inhibitory activity towards human aldehyde dehydrogenase, cefamandole produces an effect to ethanol similar to that produced by (Antabuse®). (GtoPdb)
Compound Sets
16
Cayman Chemical Bioactives
CovBinderInPDB
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NPC Screening Collection
Other bioactive compounds
ReFrame library
External IDs
61
Properties
(calculated by RDKit )
Molecular Weight
462.08
Hydrogen Bond Acceptors
10
Hydrogen Bond Donors
3
Rotatable Bonds
7
Ring Count
4
Aromatic Ring Count
2
cLogP
-0.23
TPSA
150.54
Fraction CSP3
0.33
Chiral centers
3.0
Largest ring
6.0
QED
0.37
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Bacterial
antibiotic
Pathway
Anti-infection
Indication
skin infections, urinary tract infections, respiratory tract infections
MOA
bacterial cell wall synthesis inhibitor
Therapeutic Class
Antibiotics
Source data